- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about cvs
Recent news which mentions cvs
From MarketWatch
FDA’s eye-drops recall: The full list of CVS, Walmart, Target and Rite Aid products that you should stop using ASAP
November 02, 2023
From MarketWatch
Wait for the New CEO to Get His Feet Wet Before You Trust Too Much in Walgreens' Guidance
November 02, 2023
From Motley Fool
3 Beaten-Down, High-Yield Dividend Stocks That Wall Street Predicts Could Soar More Than 25% Over the Next 12 Months
November 02, 2023
From Motley Fool
CVS Health's Health Services And Pharmacy Benefit Management Business Show Strength In Q3, But Lowers Annual GAAP EPS Outlook
November 01, 2023
Tickers
CVS
From Benzinga
CVS Health’s stock falls as company cuts full-year profit outlook, sounds downbeat note on 2024
November 01, 2023
From MarketWatch
Nasdaq, S&P 500 Futures Slide Ahead Of Fed Decision, Economic Data: Analyst Tells Why November Could Herald 'Good News'
November 01, 2023
From Benzinga
This fund manager was right that recession fears were overhyped. Now he’s betting on strip malls and these other megatrends.
November 01, 2023
From MarketWatch
From MarketWatch
Fear & Greed Index Remains In 'Fear' Zone Ahead Of Fed's Decision
November 01, 2023
From Benzinga
Kraft Heinz, Yum China And 3 Stocks To Watch Heading Into Wednesday
November 01, 2023
From Benzinga
Strike Alert 2023: Workers at CVS, Walgreens, Rite Aid Walk Out
October 30, 2023
From InvestorPlace
GSK's Competitive Edge, Surpasses Pfizer in Respiratory Syncytial Virus Vaccine Sales
October 30, 2023
From Benzinga
'Pharmageddon' - Thousands Of Pharmacists Plan Walkout To Protest Work Conditions: Report
October 30, 2023
From Benzinga
CVS, Target and other eye-drop products pose risk of dangerous infections, FDA warns
October 30, 2023
From MarketWatch
Risk of Eye Infection - FDA Issues Strong Warning on Eye Drops from Major Retailers
October 30, 2023
From Benzinga
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
October 30, 2023
From Benzinga
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
October 28, 2023
From Benzinga
Bears Roam Wall Street As Middle East Conflict, Earnings Outlook Raise Concerns Despite Strong Q3 US Economic Growth: This Week In Markets
October 27, 2023
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
October 27, 2023
From Benzinga
Jim Cramer Wants You To 'Stay Away' From This Energy Corporation: 'I've Got So Many Other Good Oil Companies'
October 27, 2023
From Benzinga
2 Absurdly Cheap Healthcare Stocks to Buy and Hold for Decades
October 26, 2023
From Motley Fool
In Need of a Turnaround: Will Walgreens' New CEO Cut or Spare Its High-Yield Dividend?
October 19, 2023
From Motley Fool
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.